4.8 Review

Integration of Host-Related Signatures with Cancer Cell-Derived Predictors for the Optimal Management of Anticancer Chemotherapy

期刊

CANCER RESEARCH
卷 70, 期 23, 页码 9538-9543

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-10-1003

关键词

-

类别

资金

  1. INSERM
  2. La Ligue contre le cancer, Fondation de France
  3. Fondation pour la Recherche Medicale
  4. Institut National du Cancer
  5. European Union
  6. Cancerople Ile-de-France
  7. Fondation Gustave Roussy
  8. AICR

向作者/读者索取更多资源

Current cancer management aims to integrate molecular signatures into the design of personalized therapies. Recent advances in omics'' done on tumor specimens have led to the identification of factors that either recognize cancers of dismal prognosis or pinpoint druggable'' signaling pathways, which can be interrupted by targeted therapies. However, accumulating evidence underscores the biological and clinical significance of immune predictors in several compartments (blood, serum, tumor) in a variety of malignancies. An additional aspect that has been overlooked is the bidirectional, tumor-host interaction during therapeutic intervention, suggesting that dynamic molecular, biochemical, and metabolic signatures should be developed in the future. We review immune parameters of prognostic or predictive value during cancer therapy, and highlight existing descriptive-prognostic'' and functional-therapeutic'' molecular signatures, with the hindsight of designing appropriate compensatory therapies. Cancer Res; 70(23); 9538-43. (C) 2010 AACR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Oncology

Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy

Amir Ajoolabady, Daolin Tang, Guido Kroemer, Jun Ren

Summary: Hepatocellular carcinoma is a prevalent form of liver cancer, with genetic, environmental, and behavioral factors influencing its development. Ferroptosis, a form of nonapoptotic cell death, has potential for suppressing hepatocellular carcinoma. However, malignant cells can develop mechanisms to resist ferroptosis.

BRITISH JOURNAL OF CANCER (2023)

Article Cell Biology

Copper-dependent autophagic degradation of GPX4 drives ferroptosis

Qian Xue, Ding Yan, Xi Chen, Xiaofen Li, Rui Kang, Daniel J. J. Klionsky, Guido Kroemer, Xin Chen, Daolin Tang, Jinbao Liu

Summary: Ferroptosis is an iron-dependent regulated cell death characterized by lipid peroxidation and membrane damage. Copper promotes ferroptotic cell death by inducing autophagic degradation of GPX4. These findings provide new insights into the connection between metal stress and autophagy-dependent cell death.

AUTOPHAGY (2023)

Review Biochemistry & Molecular Biology

Hallmarks of aging: An expanding universe

Carlos Lopez-Otin, Maria A. Blasco, Linda Partridge, Manuel Serrano, Guido Kroemer

Summary: Aging is driven by hallmarks that manifest with age, accelerate aging when accentuated experimentally, and can be decelerated, stopped, or reversed with therapeutic interventions. The twelve proposed hallmarks of aging include genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient-sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation, and dysbiosis. These hallmarks are interconnected with each other and with the recently proposed hallmarks of health.
Review Cell Biology

Meta-hallmarks of aging and cancer

Carlos Lopez-Otin, Federico Pietrocola, David Roiz-Valle, Lorenzo Galluzzi, Guido Kroemer

Summary: Both aging and cancer share similar characteristics, known as hallmarks, some of which are common metahallmarks. While some aging hallmarks suppress cancer development, others have context-dependent effects. The relationship between aging-associated nutrient-sensing and cancer-related cellular metabolism alterations is complex. Understanding the interplay between aging and cancer has significant implications for cancer morbidity and mortality in the elderly and for therapeutic strategies.

CELL METABOLISM (2023)

Article Cell Biology

Intratumor heterogeneity and cell secretome promote chemotherapy resistance and progression of colorectal cancer

Julia Kaellberg, Alexandra Harrison, Valerie March, Santa Berzina, Ivan Nemazanyy, Oliver Kepp, Guido Kroemer, Sophie Mouillet-Richard, Pierre Laurent-Puig, Valerie Taly, Wenjin Xiao

Summary: The high mortality rate in colorectal cancer (CRC) is mainly due to drug resistance caused by intratumor heterogeneity (ITH). This study investigated the interaction between different molecular subtypes of CRC cells and found that coculturing CMS1 and CMS4 cells increased their resistance to the chemotherapeutic agent 5-fluorouracil (5-FU) and promoted cellular invasion. The secretome of CMS1 cells played a protective role for CMS4 cells against 5-FU treatment and mediated the transfer of metabolites between CMS1 and CMS4 cells.

CELL DEATH & DISEASE (2023)

Article Cell Biology

Necrocide 1 mediates necrotic cell death and immunogenic response in human cancer cells

Jing Zhang, Christina Trojel-Hansen, Jianghuang Wang, Zili Zhang, Xing Wang, Yuhui Qiao, Huike Jiao, Mickael Michaud, Oliver Kepp, Marja Jäättelä, Guido Kroemer, Qing Zhong

Summary: An experimental inducer of TNF-independent necrosis, NC1, kills human cancer cells in a non-apoptotic, necrotic manner. The cell death induced by NC1 is not inhibited by apoptosis-related pathways, but depends on reactive oxygen species (ROS) production by mitochondria and elimination of mitochondrial DNA. These findings suggest that inducing regulated necrosis may be a promising approach for anticancer therapy.

CELL DEATH & DISEASE (2023)

Editorial Material Oncology

Tumor-infiltrating lymphocytes for melanoma immunotherapy

Oliver Kepp, Peng Liu, Laurence Zitvogel, Guido Kroemer

ONCOIMMUNOLOGY (2023)

Review Oncology

Trial watch: chemotherapy-induced immunogenic cell death in oncology

Jenny Sprooten, Raquel S. Laureano, Isaure Vanmeerbeek, Jannes Govaerts, Stefan Naulaerts, Daniel M. Borras, Lisa Kinget, Jitka Fucikova, Radek Spisek, Lenka Palova Jelinkova, Oliver Kepp, Guido Kroemer, Dmitri V. Krysko, An Coosemans, Rianne D. W. Vaes, Dirk De Ruysscher, Steven De Vleeschouwer, Els Wauters, Evelien Smits, Sabine Tejpar, Benoit Beuselinck, Sigrid Hatse, Hans Wildiers, Paul M. Clement, Peter Vandenabeele, Laurence Zitvogel, Abhishek D. Garg

Summary: Immunogenic cell death (ICD) is a unique process of regulated cell death that activates the immune system. The effectiveness of ICD relies on the antigenicity of dying cells and their ability to expose immunostimulatory molecules. Certain chemotherapies, such as anthracyclines, paclitaxels, and oxaliplatin, have been validated as potent ICD inducers and can be used in combination with immunotherapies against resistant tumors. This article discusses the integration of ICD-inducing chemotherapy in immuno-oncological paradigms.

ONCOIMMUNOLOGY (2023)

Article Oncology

Trial watch: Toll-like receptor ligands in cancer therapy

Julie Le Naour, Guido Kroemer

Summary: Accumulating evidence suggests that TLR agonists have favorable immune-activating effects and can be used as immunological adjuvants for cancer immunosurveillance. Several TLR agonists have been approved for oncological applications and extensively investigated. Clinical trials are ongoing to evaluate the combination of TLR agonists with other cancer treatments. Antibodies targeting tumor-enriched surface proteins conjugated with TLR agonists are also being developed to stimulate anticancer immune response within the tumor microenvironment. This review summarizes recent preclinical and clinical advances in TLR agonists for anticancer immunotherapy.

ONCOIMMUNOLOGY (2023)

Article Oncology

Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer

Vincent Carbonnier, Julie Le Naour, Thomas Bachelot, Erika Vacchelli, Fabrice Andre, Suzette Delaloge, Guido Kroemer

Summary: Formyl peptide receptor-1 (FPR1) is involved in pathogen recognition, inflammation control and cancer immunosurveillance. A single nucleotide polymorphism (SNP), rs867228, in FPR1 accelerates age at diagnosis of specific carcinomas, including luminal B breast cancer, by 4.9 years. Genetic analysis of 215 patients with metastatic luminal B breast cancer confirmed that rs867228 accelerates age of diagnosis by 6.3 years. Detection of rs867228 may be useful in breast cancer screening to start examinations at a younger age.

ONCOIMMUNOLOGY (2023)

Article Cell Biology

Impact of microbiota on breast cancer hormone therapy

Safae Terrisse, Laurence Zitvogel, Guido Kroemer

Summary: Recent observations show that hormone-receptor breast cancer is influenced by immune and microbial factors. The immune system retards the development of hormone-positive breast cancer and affects the efficacy of hormone therapy. The gut microbiota modulates the anticancer immune response, tumor microenvironment, and estrogen metabolism. Understanding these mechanisms is still in its early stages and requires further analysis.

CELL STRESS (2023)

Article Oncology

Defective Immunity Against SARS-CoV-2 Omicron Variants Despite Full Vaccination in Hematologic Malignancies

Laurence Zitvogel, Lisa Derosa, Guido Kroemer

Summary: In patients with multiple myeloma, mRNA-based vaccination schemes failed to generate detectable SARS-CoV-2 Omicron-neutralizing antibodies in approximately 60% of the cases and S1-RBD-specific CD8+ T cells in 80% of the cases. Patients who experienced breakthrough infections had very low levels of live-virus neutralizing antibodies and lacked follicular T helper cells.

BLOOD CANCER DISCOVERY (2023)

Review Cell Biology

Acyl coenzyme A binding protein (ACBP): An aging- and disease-relevant autophagy checkpoint

Lea Montegut, Mahmoud Abdellatif, Omar Motino, Frank Madeo, Isabelle Martins, Victor Quesada, Carlos Lopez-Otin, Guido Kroemer

Summary: Acyl coenzyme A binding protein (ACBP), also known as diazepam-binding inhibitor (DBI), is an ancient protein that plays a role in fatty acid metabolism and has been found to have anti-aging effects. Inhibition of ACBP can extend lifespan and improve healthspan in multiple species.

AGING CELL (2023)

Review Health Care Sciences & Services

Replication of systematic reviews: is it to the benefit or detriment of methodological quality?

Celine Chapelle, Edouard Ollier, Paul Bonjean, Clara Locher, Paul Jacques Zufferey, Michel Cucherat, Silvy Laporte

Summary: This study provides an overview of the overlap in systematic reviews (SRs) evaluating direct oral anticoagulants and characterizes these reviews in terms of bias and methodological quality. The results show a large number of replication reviews, with a fifth being excessive replications. Compared to the original SRs, the replication reviews did not improve the overall methodological quality.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2023)

Article Microbiology

The Chlamydia effector CpoS modulates the inclusion microenvironment and restricts the interferon response by acting on Rab35

Karsten Meier, Lana H. Jachmann, Goezde Tuerkoez, Mohammed Rizwan Babu Sait, Lucia Perez, Oliver Kepp, Raphael H. Valdivia, Guido Kroemer, Barbara S. Sixt

Summary: This study revealed the key role of CpoS protein from Chlamydia trachomatis in the modulation of inclusion membrane and membrane trafficking, as well as its ability to suppress interferon response through interaction with Rab GTPases. These findings advance our understanding of how intracellular bacteria shape and protect their growth niche.
暂无数据